Does concomitant administration of sevelamer hydrochloride and lanthanum carbonate modify the control of phosphatemia?

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 11, 2011, Pages 1352-1354

  Senatore, M ^a   Coppolino, G ^a   Papalia, T ^a   Greco, R ^a   Lofaro, D ^a   Bonofiglio, R ^a  

^a Unit of Geriatrics   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BICARBONATE; CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LANTHANUM CARBONATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHATE; SEVELAMER; TRIACYLGLYCEROL; CHELATING AGENT; LANTHANUM; POLYAMINE;

ADULT; AGED; ARTERIAL PH; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CROSSOVER PROCEDURE; FEMALE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; HYPOPHOSPHATEMIA; LETTER; MALABSORPTION; MALE; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; STOMACH PARESIS; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD; CHRONIC KIDNEY FAILURE; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

AGED; CHELATING AGENTS; FEMALE; HUMANS; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; LANTHANUM; MALE; MIDDLE AGED; PHOSPHATES; POLYAMINES; RENAL DIALYSIS;

EID: 84856011331     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (1)

1. NATIONAL KIDNEY FOUNFATION. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-S201.